RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Quantitative benefit-risk tradeoff preferences for Crohn’s Disease treatments: Implications for regulatory decision making and disease management
Johnson, F., Hauber, A., Ozdemir, S., Siegel, CA., Sands, BE., & Hass, S. (2009). Quantitative benefit-risk tradeoff preferences for Crohn’s Disease treatments: Implications for regulatory decision making and disease management. International Journal of Medical and Biological Frontiers, 15(5/6), 457-466.